continuation bull flag after falling wedge breakout on WW

Leading into earnings, WW who recently acquired a company that prescribes weight loss medication through telehealth with Ozempic being the hallmark medication. Earnings for this medication and service are slated to be high on rather robust earnings to begin with. We first showed interest in this stock this year near a low of 3$ and have been rolling calls all year. This is our highest ROI so far for options portfolio. For transparency we are holding 10$ strikes for october 20th on our latest roll.